AstraZeneca(us:AZN)
66.32
+1.48%
Updated on 2024-12-23
Open:65.85
Close:66.32
High:66.48
Low:65.57
Pre Close:65.35
Volume:4.64M
Amount:306.09M
Turnover:0.30%
Shares:1.55B
MarketCap:102.82B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 56 | 920990 | 0.03% | 4 | 20 | 12 |
| 2024-03-31 | 1215 | 488337689 | 15.75% | 116 | 466 | 447 |
| 2023-12-31 | 1191 | 543196472 | 17.52% | 150 | 391 | 431 |
| 2023-09-30 | 1134 | 504605574 | 16.28% | 97 | 414 | 408 |
| 2023-06-30 | 1116 | 486198214 | 15.68% | 102 | 328 | 446 |
| 2023-03-31 | 1081 | 498624464 | 16.08% | 80 | 390 | 409 |
| 2022-12-31 | 1075 | 506509719 | 16.34% | 158 | 309 | 398 |
| 2022-09-30 | 1042 | 508951277 | 16.42% | 81 | 370 | 415 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 64939661 | 2.09% | 3667687 | 5.99% |
| 2024-06-30 | Primecap Management Co/Ca/ | 42597235 | 1.37% | -347940 | -0.81% |
| 2024-06-30 | Wellington Management Group Llp | 40569917 | 1.31% | -8551944 | -17.41% |
| 2024-06-30 | Capital International Investors | 36703718 | 1.18% | 2181843 | 6.32% |
| 2024-06-30 | Fmr Llc | 22858970 | 0.74% | 2147309 | 10.37% |
| 2024-06-30 | Franklin Resources Inc | 17599960 | 0.57% | 377844 | 2.19% |
| 2024-06-30 | Jennison Associates Llc | 17023655 | 0.55% | -252627 | -1.46% |
| 2024-06-30 | Bank Of America Corp /De/ | 15860689 | 0.51% | 9635988 | 154.80% |
| 2024-06-30 | Sanders Capital, Llc | 14945242 | 0.48% | 126259 | 0.85% |
| 2024-06-30 | Goldman Sachs Group Inc | 12496350 | 0.40% | 210235 | 1.71% |
About
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Address:Cambridge Biomedical Campus,1 Francis Crick Avenue
Website:http://www.astrazeneca.co.uk
Market Movers